Abstract:Purines could be converted into uric acid in the gut microenvironment, triggering metabolic diseases, especially gout, while the uric acid excretion is impaired. However, increasing uric acid excretion remains a challenge. In this study, we prepared a uricase‐containing intestine‐targeted explosive hydrogel microspheres via gas‐shearing microfluidics for mucosal immobilization of uricase, to realize gout inhibition through a novel transporter protein regulation pathway to accelerate the uric acid excretion for the first time. After oral administration of hydrogel microspheres, uricase could be controllably released in the intestine to hydrolyze uric acid preliminarily for hydrogen peroxide production. Once exposed in the intestinal specific catalase, hydrogen peroxide would further generate a local hyperoxic microenvironment beneficial for dopamine polymerization, thereby immobilizing uricase in intestinal mucosa finally. Through this cascade reaction, only a small amount of uricase is required for local immobilization to in‐situ up‐regulate uric acid transporter proteins of intestinal epithelial cells, excreting uric acid from the epithelial cells into the intestines to be excreted, lowering the systemic uric acid level. In vitro and in vivo studies confirmed the precisely intestinal delivery of dopamine and uricase through intestine‐targeted explosive microspheres. In vitro evaluation demonstrated that the uric acid level in human fecal samples from gout patients could be significantly reduced by up to 37% by the mimic mucosa‐immobilized uricase on the isolated porcine tissues. In vivo experiments in mouse hyperuricemia model and acute gouty arthritis model confirmed that microspheres could effectively accelerate intestinal uric acid excretion, effectively increasing fecal uric acid excretion by up to 27.6% and reducing blood uric acid by up to 71%. In addition, 16S ribosomal RNA sequencing showed that the microspheres optimized intestinal flora composition, with a significant increase in probiotic bacteria such as Akkermansia muciniphila and Verrucomicrobiales, and inhibited some common intestinal bacteria in gout patients such as Bacteroidetes, thereby improving intestinal homeostasis. In conclusion, we developed a unique inducing pathway via the small intestine mucosal layer in‐situ regulation to firstly realize an efficient uric acid intestinal excretion for gout therapy. This article is protected by copyright. All rights reserved

M2 Macrophage Hybrid Membrane‐Camouflaged Targeted Biomimetic Nanosomes to Reprogram Inflammatory Microenvironment for Enhanced Enzyme‐Thermo‐Immunotherapy

Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis

Bio-inspired Nanoenzyme for Metabolic Reprogramming and Anti-Inflammatory Treatment of Hyperuricemia and Gout

Biomimetic Integrated Nanozyme for Flare and Recurrence of Gouty Arthritis

Ingenious Synergy of a Pathology-Specific Biomimetic Multifunctional Nanoplatform for Targeted Therapy in Rheumatoid Arthritis

Immunogenicity-masking delivery of uricase against hyperuricemia and gout

Mild hyperthermia enhanced synergistic uric acid degradation and multiple ROS elimination for an effective acute gout therapy

Self-modifying NanoEnhancers Facilitating Lysosomal Escape for Cgas-Sting Cascading Activation in Tumor Immunotherapy

Uricase-Expressing Engineered Macrophages Alleviate Murine Hyperuricemia

Spatial Confined Synergistic Enzymes with Enhanced Uricolytic Performance and Reduced Toxicity for Effective Gout Treatment.

The nanozymes of protein nanotubes-constructed microspheres with dual peroxidase- and catalase-like properties for M1-to-M2 macrophages repolarization and the synergistic anti-rheumatoid arthritis effect with loaded capsaicin

Intestine‐targeted Explosive Hydrogel Microsphere Promotes Uric Acid Excretion for Gout Therapy

Biomimetic and inflammation-targeted nanoparticles for rheumatoid arthritis therapy via M1-macrophages apoptosis and polarization

Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy

Macrophage membrane-camouflaged biomimetic nanoparticles for rheumatoid arthritis treatment via modulating macrophage polarization

Biomimetic micelles to accurately regulate the inflammatory microenvironment for glomerulonephritis treatment

Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats

Exploration of uricase-like activity in Pd@Ir nanosheets and their application in relieving acute gout using self-cascade reaction

Regulation of Synovial Macrophages Polarization by Mimicking Efferocytosis for Therapy of Osteoarthritis

Mastoparan M Suppressed NLRP3 Inflammasome Activation by Inhibiting MAPK/NF-B and Oxidative Stress in Gouty Arthritis

Manganese‐Based Immunomodulatory Nanocomposite with Catalase‐Like Activity and Microwave‐Enhanced ROS Elimination Ability for Efficient Rheumatoid Arthritis Therapy